CRISPR Technology Market Forecast Report | Global Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2027
Research Reports
Jan 21, 2021
The global CRISPR Technology Market is projected to reach USD 3.94 billion by 2027, according to a recent report by Emergen Research. Certain factors that are driving the market growth include increasing government and personal funding, rising demand and adoption of CRISPR, and technological advancements.
growing investment pockets evaluated in the report on Vermiculite market are powered and backed by human answers. Comprehensive coverage of aspects such as market potential, size, share, and growth aims at creating an equation for profitability- whether stakeholders, business owners, and field marketing executives need to understand their market foothold and dynamics identify the white spaces or increase their yield.
Key participants include Origene Technologies, Inc., Agilent Technologies, Cellecta, Inc., GeneCopoeia, Inc., Integrated DNA Technologies (IDT), Horizon Discovery Group, Merck KGaA, New England Biolabs, Thermo Fisher Scientific and GenScript among others.
Download Free Sample PDF Copy Of this Report at: https://www.emergenresearch.com/request-sample-form/143
Research Methodology
Data triangulation and market breakdown
Research assumptions Research data including primary and secondary data
Primary data includes breakdown of primaries and key industry insights
Secondary data includes key data from secondary sources
- Product Type Outlook (Revenue, USD Billion; 2017-2027)
- Enzymes
- Kits and Reagents
- Guide RNA
- Others
- Applications Outlook (Revenue, USD Billion; 2017-2027)
- Biomedical
- Agricultural
- Industrial
- Others
- End User Type Outlook (Revenue, USD Billion; 2017-2027)
- Pharmaceutical and Biotechnology Companies
- Academics and Government Research Institutes
- Contract Research Organizations (CROs)
- Others
Make An Enquiry: https://www.emergenresearch.com/purchase-enquiry-form/143
Beam Therapeutics primarily owned by Feng Zhang started developing CRISPR officially declared in May 2018 because of which they were able to generate USD 87 million in series A funding. The main motive of the initiative was to utilize CRISPR technology in order to develop “precision genetic medicines”. This would further help to edit a single nucleotide base in the genome at one time.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. CRISPR Technology Market Segmentation & Impact Analysis
4.1. CRISPR Technology Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rise in funding by various government and private sources
4.2.2.2. Technological advancements leading to adoption of CRISPR
4.2.3. Market restraints analysis
4.2.3.1. Heavy costs related to using CRISPR
4.2.3.2. Lack of trained professionals and standardized regulations
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. CRISPR Technology Market By Product Type Insights & Trends, Revenue (USD Million)
5.1. Product Type Dynamics & Market Share, 2019 & 2027
5.1.1. Enzymes
5.1.2. Kits and Reagents
5.1.3. Guide RNA
5.1.4. Others
Chapter 6. CRISPR Technology Market By Application Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
6.1. Application Dynamics & Market Share, 2019 & 2027
6.1.1. Biomedical
6.1.2. Agricultural
6.1.3. Industrial
6.1.4. Others
Chapter 7. CRISPR Technology Market By End User Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
7.1. End User Dynamics & Market Share, 2019 & 2027
7.1.1. Pharmaceutical and Biotechnology Companies
7.1.2. Academics and Government Research Institutes
7.1.3. Contract Research Organizations (CROs)
7.1.4. Others
To Be Continued…!
Regional Outlook (Revenue: USD Billion; 2017-2027)
- North America
- S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/crispr-technology-market
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English